News

August 2017

March 2017

November 2016

Quasar passes FDA inspection with no 483 findings

An FDA audit was conducted from October 31 to November 3 at the Quasar manufacturing facility in Shenzhen. This is the second consecutive audit Quasar has passed, by the FDA, and the result with NO findings in non-conformance (no 483) endorses Quasar's renewed commitment to being a qualified medical device manufacturer. Consistent with Quasar's legacy of maintaining high quality standards, quality is focused on throughout the entire production process, starting from development, and maintained through all phases to manufacturing.

September 2016

quasar launches new BRANDING

Quasar is pleased to launch its official new BRAND, revealing the company's strategic change in direction to reflect its focus on the medical device market. Our NEW BRANDING

March 2016

Events

ICI 2017

ICI 2017

December 4, 2017

Read more